Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering

FHS
August 31, 2023
11:53 am

Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the acquisition of BioPharmics LLC.

FDA Shoots Down Needle-Free EpiPen Alternative, Requests More Data

The FDA declined to approve an epinephrine nasal spray (ARS-1, also known as neffy), requesting that an additional premarketing study be conducted, maker ARS Pharmaceuticals

September 21, 2023

Are synthetic nicotine brands following FDA marketing guidelines?

Study finds 87% of synthetic nicotine e-cigarette posts on Instagram ignore FDA health warning requirements, emphasizing the need for stricter regulations.

September 18, 2024

UCF researcher receives $3.4 million to develop new antibiotic to treat tuberculosis

A College of Medicine researcher is developing a new antibiotic related to penicillin to treat tuberculosis (TB) and related lung infections.

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.